Sodium (o-((2,6-dichlorophenyl)-amino)-phenyl)-acetate (GP 45 840), a new non-steroidal anti-inflammatory agent.
D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000633:toxicity; D001799:Blood Sedimentation; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D007213:Indomethacin / Q000627:therapeutic use; D051379:Mice; D010648:Phenylacetates / Q000627:therapeutic use* / Q000633:toxicity; D010653:Phenylbutazone / Q000627:therapeutic use; D010973:Platelet Adhesiveness / Q000187:drug effects
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D010653:Phenylbutazone; D007213:Indomethacin